Search

everythinglearnresearchcommunity

for

Search:↓

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

The conclusion is that understanding how feathers and hairs pattern can help in developing hair regeneration treatments.

High testosterone to epitestosterone ratio in hair could predict male-pattern baldness.

Androgens significantly affect female hair loss, and hormonal treatments may help.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Seborrhea in Parkinson's disease may be linked to hormones, not autonomic impairment.

Ketoconazole reduced hair growth and improved acne in women, but caused side effects needing careful monitoring.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

Menopause significantly reduces skin collagen, leading to thinner, less elastic skin, and hormone replacement may help but requires careful consideration.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Beard and scalp hair cells have different gene expressions, which may affect beard growth characteristics.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Prolactin may be important for skin growth and immune function.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

Rutin may help treat symptoms of polycystic ovary syndrome (PCOS) in rats.

Neurosteroids change how GABA_A receptors work in the brain, which could be important for treating temporal lobe epilepsy.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

Woodhouse-Sakati syndrome often causes sexual development issues, hair loss, learning disabilities, deafness, muscle contractions, limb pain, and diabetes.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.